Shifting healthcare from reactive to proactive, Dr. Matthew Rabinowitz breaks down how preventive genomic medicine can save $200 billion annually in healthcare costs.
All in Scientist
#328 Breakthrough Biotech: CAR-Ts for Solid Tumors & Engineered Bacteria for Rare Diseases
Interviews recorded at BIO’s CEO and Investor Conference with two biotech executives: Cellinfinty Bio’s Dr. Premal Patel and Azitra’s Dr. Travis Whitfill.
#326 How DNA Solves Crimes: The Forensic Science Behind True Crime
Dr. Henry Erlich on DNA Evidence, Exonerations, and Ethical Dilemmas.
#320 Genetics in Neuromuscular Disorders: Diagnosis and Treatment with Dr. Robert Bucelli
“It Happened To Me” episode featuring Dr. Robert Bucelli on the role of genetics in diagnosing and treating neuromuscular disorders.
#318 Genetics Wrapped 2024: Top Advances in Genomic Medicine
Drs. Eric Green and Bruce Gelb join our host Kira Dineen for our annual reflection and recap on the biggest genetics/genomics advancements this year!
#313 Becker Muscular Dystrophy Clinical Trials with Edgewise Therapeutics
Dr. Joanne Donovan, Chief Medical Officer at Edgewise Therapeutics, discusses Becker Muscular Dystrophy (Becker) and emerging treatments.
#306 NIH’s Dr. Francis Collins’ Leadership in the Human Genome Project and COVID-19
The former NIH Director shares about his brand new book, The Road To Wisdom, including leading the Human Genome Project, COVID-19 pandemic, and more.
#303 RNA Analysis with Ambry Genetics
Dr. Rachid Karam explains how RNA testing increases diagnostic yield and reduces variants of uncertain significance in cancer and exomes.
#299 Genetic Causes of Epilepsy with Dr. Mattison, Dr. Oliveira and Ana Rita
The role of the ATP6V0C gene in epilepsy is explored with researcher Dr. Kari Mattison and v-ATPase Alliance’s Dr. Luis Miguel Oliveira and Ana Rita.
#297 Exome Reanalysis with Ambry Genetics
The “Patient For Life” exome reanalysis program is explored with Ambry Genetics’ Chief Medical Officer, Dr. Elizabeth Chao, and the VP of Medical Affairs and a seasoned Genetic Counselor, Kelly Hagman.
#296 Epigenetics and Beyond: Dr. John Greally's Journey
Exploring genomics while serving communities in The Bronx, the evolving study of epigenetics, and learning through personal insight from a clinical geneticist.
#294 Newborn Screening for Cancer Disposition with Dr. Lisa Diller
Dana-Farber/Boston Children’s Dr. Lisa Diller provides insight on newborn screening for childhood cancer conditions like retinoblastoma and Li-Fraumeni syndrome.
#292 TALEN® Gene Editing Technology with Cellectis
Dr. Julien Valton, explains how TALEN® gene editing technology works, what conditions are currently being worked on and the future of gene editing.
#286 Qatar Genome Program with Dr. Said Ismail
The largest genome sequencing initiative in the Middle East and the first whole-genome sequencing operation in the region to study Qatari and Arab genomes.
#278 DNA Dialogues: Rare Disease Family Experience
New podcast launch! Check out the first episode of the official Journal of Genetic Counseling Podcast, “DNA Dialogues”.
#276 Targeted DNA Methylation Sequencing with Wasatch BioLabs
Co-Founders Chad Pollard and Dr. Jonathon Hill share the importance of DNA methylation, intricacies of targeted sequencing, and future of epigenetic analysis.
#275 ALS Genetics with Dr. Patrick Short
CEO and Co-Founder of Sano Genetics shares about the genes that play a role in ALS development and the “Light The Way” free genetic testing program.
#273 ENPP1 Deficiency Disorders with Inozyme
Inozyme’s Chief Scientific Officer Dr. Yves Sabbagh and Co-President of GACI Global Christine O’Brien share their insight on these conditions.
#272 Clinical Trials for One Patient with Dr. Joe Gleeson
Episode drop of N-Lorem’s “Patient Empowerment Podcast” discussing the importance of genomics for neurology.
#271 Genetic Optic Neuropathies with Dr. Andrew Carey
Episode drop of “It Happened To Me” exploring the genetics of rare optic neuropathies.